The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
IFN-Lambda (IFN-λ) Is Expressed in a Tissue-Dependent Fashion and Primarily Acts on Epithelial Cells In Vivo
Open accessAbstract
Interferons (IFN) exert antiviral, immunomodulatory and cytostatic activities. IFN-alpha/beta (type I IFN) and IFN-lambda (type III IFN) bind distinct receptors, but regulate similar sets of genes and exhibit strikingly similar biological activities. We analyzed to what extent the IFN-alpha/beta and IFN-lambda systems overlap in vivo in terms of expression and response. We observed a certain degree of tissue specificity in the production of IFN-lambda. In the brain, IFN-alpha/beta was readily produced after infection with various RNA viruses, whereas expression of IFN-lambda was low in this organ. In the liver, virus infection induced the expression of both IFN-alpha/beta and IFN-lambda genes. Plasmid electrotransfer-mediated in vivo expression of individual IFN genes allowed the tissue and cell specificities of the responses to systemic IFN-alpha/beta and IFN-lambda to be compared. The response to IFN-lambda correlated with expression of the alpha subunit of the IFN-lambda receptor (IL-28R alpha). The IFN-lambda response was prominent in the stomach, intestine and lungs, but very low in the central nervous system and spleen. At the cellular level, the response to IFN-lambda in kidney and brain was restricted to epithelial cells. In contrast, the response to IFN-alpha/beta was observed in various cell types in these organs, and was most prominent in endothelial cells. Thus, the IFN-lambda system probably evolved to specifically protect epithelia. IFN-lambda might contribute to the prevention of viral invasion through skin and mucosal surfaces.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Rapid and efficient site-specific mutagenesis without phenotypic selection.
Kunkel, T. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.2.488 · Cited by 7,206
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
The IFNB Multiple Sclerosis Study Group (1993) · Neurology · doi:10.1212/wnl.43.4.655 · Cited by 2,085
Paty, D. W., Li, D. K. B., the UBC MS/MRI Study Group, & the IFNB Multiple Sclerosis Study Group (1993) · Neurology · doi:10.1212/wnl.43.4.662 · Cited by 1,967
IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex
Kotenko, S. V., Gallagher, G., Baurin, V. V., Lewis-Antes, A., Shen, M., Shah, N. K., Langer, J. A., Sheikh, F., Dickensheets, H., & Donnelly, R. P. (2003) · Nature Immunology · doi:10.1038/ni875 · Cited by 1,868
Interferons, interferon‐like cytokines, and their receptors
Pestka, S., Krause, C. D., & Walter, M. R. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00204.x · Cited by 1,766
IL-28, IL-29 and their class II cytokine receptor IL-28R
Sheppard, P., Kindsvogel, W., Xu, W., Henderson, K., Schlutsmeyer, S., Whitmore, T. E., Kuestner, R., Garrigues, U., Birks, C., Roraback, J., et al. (2003) · Nature Immunology · doi:10.1038/ni873 · Cited by 1,570
Girard, M., Duquette, P., & Sibley, W. A. (1993) · Cited by 1,196
Role of deficient type III interferon-λ production in asthma exacerbations
Contoli, M., Message, S. D., Laza-Stanca, V., Edwards, M. R., Wark, P. A. B., Bartlett, N. W., Kebadze, T., Mallia, P., Stanciu, L. A., Parker, H. L., et al. (2006) · Nature Medicine · doi:10.1038/nm1462 · Cited by 1,006
Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures
Goodbourn, S., Didcock, L., & Randall, R. E. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-10-2341 · Cited by 977
Isaacs, A., & Lindenmann, J. (2015) · The Journal of Immunology · doi:10.1093/jimmunol/195.5.1911 · Cited by 602
Ank, N., West, H., Bartholdy, C., Eriksson, K., Thomsen, A. R., & Paludan, S. R. (2006) · Journal of Virology · doi:10.1128/jvi.80.9.4501-4509.2006 · Cited by 596
Coccia, E. M., Severa, M., Giacomini, E., Monneron, D., Remoli, M. E., Julkunen, I., Cella, M., Lande, R., & Uzé, G. (2004) · European Journal of Immunology · doi:10.1002/eji.200324610 · Cited by 490
Neuropsychiatric Adverse Effects of Interferon-??: Recognition and Management
Raison, C. L., Demetrashvili, M., Capuron, L., & Miller, A. H. (2005) · CNS Drugs · doi:10.2165/00023210-200519020-00002 · Cited by 483
Zhou, Z., Hamming, O. J., Ank, N., Paludan, S. R., Nielsen, A. L., & Hartmann, R. (2007) · Journal of Virology · doi:10.1128/jvi.02438-06 · Cited by 479
Neuropsychiatric Symptoms Associated With Hepatitis C and Interferon Alpha: A Review
Dieperink, E., Willenbring, M., & Ho, S. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.6.867 · Cited by 422
Viral Infections Activate Types I and III Interferon Genes through a Common Mechanism
Onoguchi, K., Yoneyama, M., Takemura, A., Akira, S., Taniguchi, T., Namiki, H., & Fujita, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608618200 · Cited by 355
Plagemann, P. G. W., & Moennig, V. (1992) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60036-6 · Cited by 341
Dumoutier, L., Tounsi, A., Michiels, T., Sommereyns, C., Kotenko, S. V., & Renauld, J.-C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404789200 · Cited by 291
Self-citationInterferon-κ, a Novel Type I Interferon Expressed in Human Keratinocytes
LaFleur, D. W., Nardelli, B., Tsareva, T., Mather, D., Feng, P., Semenuk, M., Taylor, K., Buergin, M., Chinchilla, D., Roshke, V., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102502200 · Cited by 288
Yang, K., Puel, A., Zhang, S., Eidenschenk, C., Ku, C.-L., Casrouge, A., Picard, C., von Bernuth, H., Senechal, B., Plancoulaine, S., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.016 · Cited by 272
Signaling pathways activated by interferons
Platanias, L. C., & Fish, E. N. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(99)00109-5 · Cited by 270
Neurons produce type I interferon during viral encephalitis
Delhaye, S., Paul, S., Blakqori, G., Minet, M., Weber, F., Staeheli, P., & Michiels, T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602460103 · Cited by 266
Self-citationIL-28 and IL-29: Newcomers to the interferon family
Uzé, G., & Monneron, D. (2007) · Biochimie · doi:10.1016/j.biochi.2007.01.008 · Cited by 260
Lasfar, A., Lewis-Antes, A., Smirnov, S. V., Anantha, S., Abushahba, W., Tian, B., Reuhl, K., Dickensheets, H., Sheikh, F., Donnelly, R. P., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3653 · Cited by 254
Interferon induces a unique protein in mouse cells bearing a gene for resistance to influenza virus.
Horisberger, M. A., Staeheli, P., & Haller, O. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.7.1910 · Cited by 245
Self-citationLevraud, J.-P., Boudinot, P., Colin, I., Benmansour, A., Peyrieras, N., Herbomel, P., & Lutfalla, G. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4385 · Cited by 242
Domanski, P., Witte, M., Kellum, M., Rubinstein, M., Hackett, R., Pitha, P., & Colamonici, O. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.21606 · Cited by 241
Characterization of the type I interferon locus and identification of novel genes☆
Hardy, M. P., Owczarek, C. M., Jermiin, L. S., Ejdebäck, M., & Hertzog, P. J. (2004) · Genomics · doi:10.1016/j.ygeno.2004.03.003 · Cited by 238
Jaitin, D. A., Roisman, L. C., Jaks, E., Gavutis, M., Piehler, J., Van der Heyden, J., Uze, G., & Schreiber, G. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.5.1888-1897.2006 · Cited by 225
Differential Receptor Subunit Affinities of Type I Interferons Govern Differential Signal Activation
Jaks, E., Gavutis, M., Uzé, G., Martal, J., & Piehler, J. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.11.053 · Cited by 223
Human interferon lambda-1 (IFN-λ1/IL-29) modulates the Th1/Th2 response
Jordan, W. J., Eskdale, J., Srinivas, S., Pekarek, V, Kelner, D., Rodia, M., & Gallagher, G. (2007) · Genes & Immunity · doi:10.1038/sj.gene.6364382 · Cited by 206
Brand, S., Beigel, F., Olszak, T., Zitzmann, K., Eichhorst, S. T., Otte, J.-M., Diebold, J., Diepolder, H., Adler, B., Auernhammer, C. J., et al. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00126.2005 · Cited by 205
Protective Role of Beta Interferon in Host Defense against Influenza A Virus
Koerner, I., Kochs, G., Kalinke, U., Weiss, S., & Staeheli, P. (2007) · Journal of Virology · doi:10.1128/jvi.01718-06 · Cited by 201
Self-citationTeige, I., Treschow, A., Teige, A., Mattsson, R., Navikas, V., Leanderson, T., Holmdahl, R., & Issazadeh-Navikas, S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4776 · Cited by 200
Antitumor Activity of IFN-λ in Murine Tumor Models
Sato, A., Ohtsuki, M., Hata, M., Kobayashi, E., & Murakami, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7686 · Cited by 195
IFN-λ: Novel Antiviral Cytokines
Ank, N., West, H., & Paludan, S. R. (2006) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2006.26.373 · Cited by 193
Characterization of the Murine Alpha Interferon Gene Family
van Pesch, V., Lanaya, H., Renauld, J.-C., & Michiels, T. (2004) · Journal of Virology · doi:10.1128/jvi.78.15.8219-8228.2004 · Cited by 192
Self-citationBlakqori, G., Delhaye, S., Habjan, M., Blair, C. D., Sánchez-Vargas, I., Olson, K. E., Attarzadeh-Yazdi, G., Fragkoudis, R., Kohl, A., Kalinke, U., et al. (2007) · Journal of Virology · doi:10.1128/jvi.01933-06 · Cited by 190
Self-citationÖsterlund, P., Veckman, V., Sirén, J., Klucher, K. M., Hiscott, J., Matikainen, S., & Julkunen, I. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9608-9617.2005 · Cited by 183
THE GENETICS OF THE PERSISTENT INFECTION AND DEMYELINATING DISEASE CAUSED BY THEILER'S VIRUS
Brahic, M., Bureau, J., & Michiels, T. (2005) · Annual Review of Microbiology · doi:10.1146/annurev.micro.59.030804.121242 · Cited by 140
Self-citationDUMOUTIER, L., LEJEUNE, D., HOR, S., FICKENSCHER, H., & RENAULD, J.-C. (2003) · Biochemical Journal · doi:10.1042/bj20021935 · Cited by 128
Modulation of the human cytokine response by interferon lambda-1 (IFN-λ1/IL-29)
Jordan, W. J., Eskdale, J., Boniotto, M., Rodia, M. T., Kellner, D. B., & Gallagher, G. E. (2006) · Genes and Immunity · doi:10.1038/sj.gene.6364348 · Cited by 128
Blakqori, G., & Weber, F. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10420-10428.2005 · Cited by 122
Bartlett, N., Buttigieg, K., Kotenko, S., & Smith, G. L. (2005) · Journal of General Virology · doi:10.1099/vir.0.80904-0 · Cited by 117
Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection
Neuhaus, O., Archelos, J. J., & Hartung, H. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00028-2 · Cited by 111
Type I interferon response in the central nervous system
Paul, S., Ricour, C., Sommereyns, C., Sorgeloos, F., & Michiels, T. (2007) · Biochimie · doi:10.1016/j.biochi.2007.02.009 · Cited by 106
Self-citationMurine hepatitis virus--A model for virus-induced CNS demyelination
Matthews, A., Weiss, S., & Paterson, Y. Y. W. (2002) · Journal of NeuroVirology · doi:10.1080/13550280290049534 · Cited by 87
Optimisation of intradermal DNA electrotransfer for immunisation
Vandermeulen, G., Staes, E., Vanderhaeghen, M.-L., Bureau, M. F., Scherman, D., & Véronique Préat, A. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.08.010 · Cited by 85
Stueckemann, J. A., Holth, M., Swart, W. J., Kowalchyk, K., Smith, M. S., Wolstenholme, A. J., Cafruny, W. A., & Plagemann, P. G. W. (1982) · Journal of General Virology · doi:10.1099/0022-1317-59-2-263 · Cited by 77
Type I interferons and limitin: a comparison of structures, receptors, and functions
Oritani, K., Kincade, P. W., Zhang, C., Tomiyama, Y., & Matsuzawa, Y. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00009-0 · Cited by 72
Human primary immunodeficiencies of type I interferons
Jouanguy, E., Zhang, S., Chapgier, A. L. A., Sancho‐Shimizu, V., Puel, A., Pïcard, C., Boisson‐Dupuis, S., Abel, L., & Casanova, J. (2007) · Biochimie · doi:10.1016/j.biochi.2007.04.016 · Cited by 71
Li, S., Zhang, X., Xia, X., Zhou, L., Breau, R., Suen, J. Y., & Hanna, E. Y. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301418 · Cited by 66
Thymus involution induced by mouse hepatitis virus A59 in BALB/c mice
Godfraind, C., Holmes, K. V., & Coutelier, J. P. (1995) · Journal of Virology · doi:10.1128/jvi.69.10.6541-6547.1995 · Cited by 65
DeWever, J., Frérart, F., Bouzin, C., Baudelet, C., Ansiaux, R., Sonveaux, P., Gallez, B., Dessy, C., & Féron, O. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060968 · Cited by 48
Paul, S., & Michiels, T. (2006) · Journal of General Virology · doi:10.1099/vir.0.81642-0 · Cited by 46
Self-citationCharacterization of Interferon-α 13, a Novel Constitutive Murine Interferon-α Subtype
Pesch, V. V., & Michiels, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302554200 · Cited by 40
Self-citationImmunotherapeutic approaches in multiple sclerosis
Adorini, L. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.04.014 · Cited by 38
Pathogenesis of Theiler’s murine encephalomyelitis virus‐induced disease
Roos, R. P. (2010) · Clinical and Experimental Neuroimmunology · doi:10.1111/j.1759-1961.2010.00008.x · Cited by 30
N-Glycosylation of Murine IFN- β in a Putative Receptor-Binding Region
Sommereyns, C., & Michiels, T. (2006) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2006.26.406 · Cited by 11
Self-citation
Cited by
Interferon-stimulated genes: A complex web of host defenses
Schneider, W. M., Chevillotte, M. D., & Rice, C. M. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120231 · Cited by 3,067
Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
Ouyang, W., Rutz, S., Crellin, N. K., Valdez, P. A., & Hymowitz, S. G. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101312 · Cited by 1,925
Shared and Distinct Functions of Type I and Type III Interferons
Lazear, H. M., Schoggins, J. W., & Diamond, M. S. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.025 · Cited by 1,138
Guarding the frontiers: the biology of type III interferons
Wack, A., Terczyńska-Dyla, E., & Hartmann, R. (2015) · Nature Immunology · doi:10.1038/ni.3212 · Cited by 364
Induction and function of type I and III interferon in response to viral infection
Levy, D. E., Marié, I. J., & Durbin, J. E. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.11.001 · Cited by 314
Metadata
- Authors
- Sommereyns, C., Paul, S., Staeheli, P., & Michiels, T.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-03-14
- Volume
- 4
- Issue
- 3
- Pages
- e1000017
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W2013202475
- Cited by
- 772
- References
- 61
- FWCI
- 14.17
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.